Key Takeaways
-
Two practices with identical EBITDA can sell for very different prices because buyer competition, deal structure, and negotiation can matter as much as the financials.
-
Building normalized EBITDA works best as a 24-month sequence. Hygiene utilization above 30%, a stronger payer mix, documented add-backs, and reduced owner dependency can all support higher multiples.
-
Pre-sale capital expenditures rarely add dollar-for-dollar value. Investments that increase production, cut overhead, or resolve clear buyer concerns are the ones that tend to improve sale price.
-
Creating genuine buyer competition by running private and institutional paths at the same time can deliver 15–30% higher sale prices than single-buyer negotiations.
-
McLerran & Associates runs a diligence-grade valuation and structured auction process for dental practice owners.
Schedule a free, confidential discovery call with McLerran & Associates.
How To Calculate What Your Dental Practice Is Actually Worth
Dental practice valuation starts with normalized cash flow. Buyers, whether individual dentists or institutional acquirers, calculate what the practice earns after removing owner-specific expenses, one-time costs, and personal items run through the business. That normalized figure is adjusted EBITDA for institutional buyers, or Seller’s Discretionary Earnings (SDE, meaning the total financial benefit available to a single owner-operator) for smaller, privately sold practices.
Once normalized earnings are established, a multiple is applied. Two practices each collecting $1.5 million can have very different values. A practice producing $400,000 in adjusted EBITDA and another producing $200,000 will not be worth the same to any buyer.
For smaller practices, generally those with collections under $1.5 million, SDE-based valuation is typical. Published sold-transaction data places dental practices in a range of roughly 1.6x to 3.4x SDE. Practices in the $500,000–$1,000,000 SDE range tend to cluster near 2.8x. For larger practices, institutional buyers price on adjusted EBITDA instead. The ranges widen considerably based on practice size, specialty, provider depth, revenue durability, and payer mix.
Several factors can move a practice toward the higher end of its applicable range:
-
Practice size and EBITDA scale. Larger practices with higher adjusted EBITDA can command higher multiples. Buyers see lower key-person risk and stronger operational infrastructure.
-
Provider depth. Adding even one producing associate dentist can move an owner-dependent practice up about a full turn of EBITDA multiple. Buyers pay more for collections that transfer cleanly after the owner’s exit.
-
Revenue durability and payer mix. Payer mix can be some of the main factors affecting a practice’s multiple after practice size. Practices with 60% or more fee-for-service revenue often command full multiples or above, while heavy Medicaid exposure can compress the multiple and narrow the buyer pool.
-
Hygiene production. Hygiene revenue above 30% of collections is tied to premium multiples and stronger offers. Buyers see recurring, transferable revenue that does not depend on the selling doctor.
-
Specialty. Oral and maxillofacial surgery can command some of the highest multiples and remains a fast-consolidating segment. Orthodontics and pediatric dentistry draw strong institutional interest. General dentistry still earns aggressive, near-all-time-high valuations. Lighter-demand specialties tend to sit at the lower end of applicable ranges.
On the topic of “average EBITDA for dental practice” and “dental practice multiples” as benchmarks, EBITDA margins for general dentistry typically range from 18% to 30%, with a healthy median near 24%. Multiples function as ranges. A practice’s specific multiple depends on its own numbers, market, and buyer pool rather than an industry average.
Find out what your practice is really worth.
How To Build The Number: A 24-Month Sequencing Playbook
Operational improvements that increase EBITDA take time to show up in the financials that buyers review. Starting early and in a deliberate order can separate a practice that commands a premium from one that leaves money on the table.
24+ Months Out: Profitability, Hygiene Utilization, Payer Mix, And Add-Back Documentation
The highest-leverage work begins furthest from the sale. At this stage, the priority is increasing normalized EBITDA and documenting every dollar of it.
Hygiene utilization is one of the most durable revenue drivers a buyer can underwrite. Buyers track hygiene reappointment rate, 6-month recall compliance, and hygiene-to-restorative conversion rate in diligence. Building hygiene to 30% or more of total collections, and documenting that trend over multiple years, creates a recurring revenue story that can support a premium multiple.
Payer mix improvement works best as a multi-year effort. Reducing Medicaid exposure or shifting toward fee-for-service and PPO revenue takes time to flow through the financials. Starting this work 24+ months out means buyers see a favorable trend instead of a one-year anomaly.
Add-back documentation is where many owners leave money on the table. A documented add-back schedule with a paper trail can be one of the highest-leverage pre-sale steps, because unsupported add-backs are likely to be struck in quality-of-earnings diligence, and each dollar added back can be worth five to eight dollars in value at closing. Start by listing every expense the practice pays that benefits you personally rather than the business, such as above-market owner compensation, a personal vehicle, family members on payroll, and one-time costs. Each item can raise normalized earnings when you can show a buyer the documentation behind it.
Owner dependency reduction also begins at this stage. A common path to reducing key-person risk is to hire a full-time associate at least 18–24 months before a planned sale, document their production trend, and step back from a majority of chair time incrementally. Dental practices where the owner-dentist personally performs 90% or more of production can face a 10–20% valuation reduction because buyers struggle to underwrite production revenue that may leave with the seller.
12 Months Out: Systems Documentation, Transferability Of Revenue, And Team Depth
At 12 months out, the focus shifts from building EBITDA to making it transferable. A buyer is purchasing your earnings and the likelihood that those earnings will continue after you leave.
Systems documentation means written protocols for scheduling, billing, recall, and clinical workflows that do not depend on the owner’s memory. Practices that run on documented systems tend to carry lower transition risk and can be valued accordingly.
Staff and provider depth matters to every buyer type. Long-tenured staff can be a value driver, while high turnover often leads to a discount. An associate who has been building patient relationships for 2 or more years becomes a transferability asset. A practice where every patient relationship runs through the owner presents higher risk.
Lease review belongs at this stage. Buyers often want a minimum remaining lease term of 7–10 years with renewal options. A short lease creates renegotiation risk that buyers may price in or treat as a reason to walk away.
6 Months Out: Data Room Preparation, Financial Cleanup, And Equipment Choices
At 6 months out, the work becomes more transactional. A virtual data room, meaning a secure and organized repository of everything a buyer will need to evaluate the practice, should be assembled before the practice goes to market.
Financial statement cleanup means 3 years of clean, consistent financials with personal expenses removed from the books. Quality-of-earnings reviews now often run 60–90 days with real operational disruption, and buyers increasingly push back on EBITDA adjustments that might have gone unchallenged several years ago. Practices without pre-market financial preparation can enter diligence at a disadvantage.
Equipment decisions require discipline. The next section outlines a framework for deciding whether a pre-sale capital expenditure is likely to pay off.
At Market: Buyer List Construction And Process Design
Once a practice goes to market, process design can influence the outcome as much as the financials. A structured, competitive process that reaches individual dentists, associates, and institutional buyers at the same time creates the tension that can push price up. A single-buyer negotiation, even with a strong P&L, often caps the price at whatever that one buyer is willing to pay. Process design can be a primary value driver.
How To Decide Whether A Pre-Sale Investment Actually Pays Off
Many dental practice owners spend significant capital on improvements in the final 12–24 months before a sale and expect those projects to translate directly into a higher price. That outcome rarely occurs.
A simple framework can guide any pre-sale capital expenditure. An investment tends to help when it increases production, reduces expense, or resolves a specific buyer concern. When none of those apply, the investment is unlikely to increase the sale price by more than it costs.
A $200,000 remodel does not add $200,000 to the sale price. Buyers apply a multiple to EBITDA, not to the replacement cost of a buildout. A remodel that does not increase production or reduce overhead leaves EBITDA unchanged and usually leaves valuation unchanged. A remodel can make the practice more appealing during a tour, but it does not change the EBITDA a buyer is pricing.
Equipment purchases follow the same logic. Deferred technology capital expenditure, such as aging operatories without cone-beam CT, no digital impressions, paper charts, and outdated sterilization equipment, can signal a $100,000–$500,000 upgrade cost that buyers normalize against purchase price, which can result in a multiple adjustment. Addressing genuine technology gaps that buyers will likely flag in diligence can be worth the investment. Upgrading equipment that already meets buyer expectations generally does not change valuation meaningfully.
The investments that more reliably pay off before a sale are those that directly increase normalized EBITDA. Examples include hiring an associate who adds production, improving hygiene recall to increase recurring revenue, and documenting add-backs that a buyer’s quality-of-earnings team might otherwise strike. At a 7x EBITDA multiple, $100,000 of clean, documented add-backs can translate into $700,000 of additional sale price. Many owners use that standard when weighing pre-sale expenditures.
Request a comprehensive practice valuation.
How To Sell The Number: The Negotiation-Side Levers That Influence Net Proceeds
Building a strong EBITDA is necessary, yet it is only one phase of the outcome. Three negotiation-side levers determine how much of that EBITDA actually reaches your bank account: buyer competition, deal structure, and the specific terms of the letter of intent (LOI).
Buyer Competition: The Most Powerful Lever In The Process
A single-buyer negotiation can cap the price regardless of how strong the P&L looks. In 2024, dental practices achieved an average of 108% of asking price, a result that tends to occur when multiple buyers are competing. Creating competition among individual dentists, associates, institutional buyers, and private-equity-backed groups at the same time is the process design that can support that type of outcome.
Different buyer types value the same practice differently. For larger or better-positioned practices, institutional buyers can sometimes pay 30% to 50% more than individual dentist buyers. Below roughly $1 million in collections, individual dentists can still be competitive. Running both paths simultaneously, rather than one after the other, is what creates genuine competitive tension.
Deal Structure: Where The Headline Price And The Real Number Diverge
Two identical headline prices can net very different amounts depending on how the deal is structured. Several components can determine real net proceeds:
-
Cash at close. Cash-at-close percentages in dental practice deals have shifted from an average of roughly 80% in 2022 to closer to 65% in 2026. The deferred portion has grown, which moves more risk to the seller even when the headline number appears unchanged.
-
Earnout terms. Institutional buyers commonly structure 15% to 35% of the purchase price as earnout payments tied to collections or EBITDA over 1 to 3 years. The metric definition matters. An earnout tied to EBITDA as defined by the buyer, who controls overhead allocation after close, can be difficult to achieve. Earnouts tied to revenue or gross collections are often more straightforward for sellers.
-
Rollover equity. As much as 40% of an institutional deal can be paid in equity rather than cash. That equity remains illiquid until the buyer recapitalizes, typically 3–7 years away, and carries risk. A $3.5 million institutional offer might deliver only $2.2 million at closing. Another $600,000 could be tied to earnout targets the seller cannot control, and $700,000 could sit in equity that is inaccessible for 5 to 10 years. A private buyer’s $2.8 million, by contrast, is fully liquid at closing.
-
Escrow and holdback. An escrow or holdback reduces immediate proceeds and can remain tied up while indemnification claims are resolved. Negotiating the amount, duration, and whether the holdback is the buyer’s sole and exclusive remedy can help cap the seller’s downside.
-
Working-capital adjustments. Working-capital adjustments in dental practice sales typically run ±2–3% and are often best pre-negotiated before the LOI is signed. Clear terms can help avoid post-close drag on net proceeds.
-
Tax allocation. Under IRC 1060, a dental practice sale is allocated across asset classes, and the seller pays long-term capital gains rates on goodwill but ordinary income rates on equipment recapture and the covenant not to compete. Every dollar moved from goodwill to the covenant not to compete can cost a top-bracket seller approximately 17 cents of additional federal tax. Tax allocation functions as a negotiation point, not just a formality.
The LOI is where many of these terms are set. Most provisions in a dental practice LOI are non-binding, yet the terms agreed to there create the negotiating baseline, and changing them later often requires reopening discussions when the seller has less leverage. Buyer competition can be used to lock in favorable structure before exclusivity narrows the seller’s options.
Create competition for your dental practice sale.
Running both the valuation phase and the negotiation phase well usually calls for an advisor who has managed that process many times. The next section outlines how McLerran & Associates approaches that work.
How McLerran & Associates Approaches The Sale Process
McLerran & Associates focuses exclusively on dental practice owners who want to understand and improve their sale outcome. The firm positions its work as education-first and represents practice owners, not buyers.
For roughly 35 years, McLerran & Associates has operated as a dental-only sell-side advisor and advocate. The firm has completed approximately 2,000 successful practice sales, closed roughly $2 billion in transaction volume, and evaluated more than 10,000 dental practices. Its team brings over 100 years of collective dental-industry experience as former investment bankers, practice-finance lenders, institutional buyers, CPAs, and advisors.
McLerran engagements begin with a CPA-led EBITDA analysis built from the ground up. The team accesses the practice management system remotely, cross-references data against financials, and unpacks and documents every add-back. This diligence-grade work is designed to hold up when a buyer’s quality-of-earnings team reviews it and to reduce the risk of re-trading at the negotiating table.
From that foundation, McLerran creates competition. The firm runs a structured, auction-like bid process, typically over 45–60 days, that can generate multiple offers from a vetted pool of qualified buyers. Poorly run institutional buyers are screened out so owners see a clearer view of the market and can negotiate from a stronger position.
McLerran works both transition paths, private-buyer (doctor-to-doctor) and institutional affiliation, in roughly equal measure. That 50/50 split gives owners a side-by-side comparison that single-lane brokers may not provide, which can be especially useful for practices that could fit either path.
For owners who are still exploring options, the McLerran M&A Summit (October 29–30, 2026) offers a way to learn before committing to a process. The event awards 4 CE credits and includes a complimentary practice valuation, a $2,500 value, for attendees.
Talk through your practice’s valuation with a dental-only advisor.
Frequently Asked Questions About Dental Practice Sale Price
How Much Should A Dental Practice Sell For?
A dental practice’s sale price is driven by its normalized cash flow, meaning adjusted EBITDA or SDE, and the multiple applied to that figure. For smaller, privately sold practices, published sold-transaction data places dental practices in a range of roughly 1.6x to 3.4x SDE. For larger practices sold to institutional buyers, multiples typically range from the mid-single digits to the low double digits depending on practice size, specialty, provider depth, payer mix, and revenue durability. The ADA’s 65%–85% collections rule of thumb can serve as a starting point and tends to break down as profitability diverges from collections. In practice, a specific valuation depends on the practice’s own numbers and market.
What Is The 2-Year Rule For Dentists?
The “2-year rule” refers to the common benchmark that buyers and lenders look at 2 years, and often 3 years, of stable, documented financials when evaluating a dental practice. Lenders financing a private-buyer dental practice acquisition typically require 3 years of personal and practice tax returns, with practice management and production reports used to verify those returns and support a Debt Service Coverage Ratio of at least 1.25×, though 2 years of practice operating history is generally the practical minimum. Institutional buyers run quality-of-earnings analyses covering a similar period. This timing is why financial statement cleanup, consistent add-back documentation, and removal of personal expenses from the books can work best when they begin 24 months or more before a planned sale.
What Is The 3-3-3 Dental Rule?
The “3-3-3 rule” is a rule of thumb sometimes used in dental practice discussions to describe a simplified valuation framework. Like most rules of thumb, it can serve as a rough orientation and can miss key details in practice. It does not account for payer mix, provider depth, hygiene utilization, or the difference between a practice priced for a private buyer versus an institutional acquirer. A practice generating $3 million in collections with strong EBITDA, an associate bench, and a commercial payer mix will likely command a different multiple than one with the same collections but high owner dependency and Medicaid exposure. The 3-3-3 framework can start a conversation and does not replace a formal valuation.
What Is The 80/20 Rule In Dentistry?
The 80/20 rule in dentistry, drawn from the broader Pareto principle, describes the observation that roughly 80% of a practice’s revenue often comes from roughly 20% of its patients, or that 80% of production may come from 20% of procedures or providers. In a valuation context, this concentration principle matters because it can create risk. A practice where 80% of revenue flows through the owner-dentist personally is a higher-risk asset for any buyer, since revenue may leave with that dentist. Similarly, a practice where 80% of new patients come from a single referral source carries concentration risk that buyers may discount. Buyers tend to pay more for diversification across providers, procedures, payer types, and patient sources because diversification can make revenue more transferable and durable after the sale.
The Path To Your Maximum Outcome Starts Now
The final sale price of a dental practice reflects two phases: building the number and selling the number. Many owners spend years on the first and only a short period on the second, even though the second phase can determine the difference between a good outcome and a great one. Buyer competition, deal structure, LOI terms, tax allocation, and the quality of the advisor running the process can move real net proceeds by hundreds of thousands of dollars on the same underlying EBITDA.
McLerran & Associates operates as a dental-only sell-side advisor and advocate focused on running both phases on behalf of practice owners. With roughly 35 years in business and approximately 2,000 successful practice sales, the firm concentrates on helping owners see the full range of options and structure a sale that aligns with their goals.
To discuss your practice, your goals, and your options, whether now or in the future, you can reach out directly:
-
Phone: (512) 900-7989
-
Email: info@dentaltransitions.com
-
Web: dentaltransitions.com/contact-us
Schedule a free, confidential discovery call with McLerran & Associates.
